BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30671602)

  • 1. Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?
    Ant A; Yazici Ö; Atabey P; Aslan FF; Duran A; Ozlugedik S; Kemaloglu YK
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):977-984. PubMed ID: 30671602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.
    Cho TY; Cheng PW; Young YH
    Laryngoscope; 2016 Sep; 126(9):2016-21. PubMed ID: 26864918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy.
    Tsang RK; Kwong DL; Ho AC; To VS; Ho WK; Wei WI
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(4):228-33. PubMed ID: 22907195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated ears in nasopharyngeal carcinoma survivors: A review.
    Young YH
    Laryngoscope; 2019 Mar; 129(3):637-642. PubMed ID: 30194730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
    Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
    Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
    Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.
    Wang SZ; Li J; Miyamoto CT; Chen F; Zhou LF; Zhang HY; Yang G; Wang WF; Guo M; Ni XC; Wang L
    Radiother Oncol; 2009 Dec; 93(3):530-3. PubMed ID: 19853315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hearing status after radiotherapy for nasopharyngeal carcinoma.
    Low WK; Fong KW
    Auris Nasus Larynx; 1998 Jan; 25(1):21-4. PubMed ID: 9512790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
    Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
    Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
    Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
    Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
    Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Du T; Xiao J; Qiu Z; Wu K
    PLoS One; 2019; 14(7):e0219611. PubMed ID: 31291379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of radiotherapy on retro-cochlear auditory pathways.
    Low WK; Burgess R; Fong KW; Wang DY
    Laryngoscope; 2005 Oct; 115(10):1823-6. PubMed ID: 16222203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Significant Carotid Stenosis for Nasopharyngeal Carcinoma between Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy.
    Liao W; Zhou H; Fan S; Zheng Y; Zhang B; Zhao Z; Xiao S; Bai S; Liu J
    Sci Rep; 2018 Sep; 8(1):13899. PubMed ID: 30224668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta-analysis and a systematic review of the literature.
    Co J; Mejia MB; Dizon JM
    Head Neck; 2016 Apr; 38 Suppl 1():E2130-42. PubMed ID: 25546181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma: intensity-modulated radiotherapy versus conventional radiotherapy].
    Zhang Y; Lin ZA; Pan JJ; Zheng Z; Yang L; Lin SJ; Zheng F
    Ai Zheng; 2009 Nov; 28(11):1143-8. PubMed ID: 19895733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late effects of radiotherapy on hearing.
    Schot LJ; Hilgers FJ; Keus RB; Schouwenburg PF; Dreschler WA
    Eur Arch Otorhinolaryngol; 1992; 249(6):305-8. PubMed ID: 1418938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.